REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro de Diagnostico Urologico S.A. C.D.U.S.A. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Centro de Diagnostico Urologico S.A. C.D.U.S.A. Profile Updated: August 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Centro de Diagnostico Urologico S.A. C.D.U.S.A. is based in Colombia, with the head office in Manizales. The company operates in the Ambulatory Health Care Services industry. The company was established on September 24, 1998. 63 (2024) employees currently work for Centro de Diagnostico Urologico S.A. C.D.U.S.A.. There was a net sales revenue increase of 27.86% reported in Centro de Diagnostico Urologico S.A. C.D.U.S.A.’s latest financial highlights for 2023. During that time, Centro de Diagnostico Urologico S.A. C.D.U.S.A.’s total assets grew by 55.88%. The net profit margin of Centro de Diagnostico Urologico S.A. C.D.U.S.A. decreased by 2.45% in 2023.

Headquarters
Cra 27 66-30
Manizales; Caldas;

Contact Details: Purchase the Centro de Diagnostico Urologico S.A. C.D.U.S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Centro de Diagnostico Urologico S.A. C.D.U.S.A. report to view the information.
Outstanding Shares:
Purchase the Centro de Diagnostico Urologico S.A. C.D.U.S.A. report to view the information.
Incorporation Date:
September 24, 1998
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro de Diagnostico Urologico S.A. C.D.U.S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
27.86%
Total operating revenue
27.86%
Operating profit (EBIT)
19.39%
EBITDA
23.89%
Net Profit (Loss) for the Period
-16.25%
Total assets
55.88%
Total equity
18.8%
Operating Profit Margin (ROS)
-1.05%
Net Profit Margin
-2.45%
Return on Equity (ROE)
-4.82%
Debt to Equity Ratio
22.71%
Quick Ratio
-0.65%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?